Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Index funds offer low fees and broad diversification, making them a solid default choice for long-term investors.
26,735 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
A clear, practical look at Bowhead Specialty's Q4 2025 earnings transcript. Learn what the numbers mean, which metric...
U.S. manufacturers grow second month in a row in February, but tariff-driven pricing pressures and volatile metal cos...
Oil futures surged to fresh highs, weighing on Nvidia, Amazon, and Meta as energy costs threaten ad budgets and data-...
HeartBeam heads into 2025 earnings with a mix of potential breakthroughs and headwinds. This guide explains what the ...
A private equity round closes March 19 for an IP rights company that reserved a Nasdaq ticker, signaling rising inves...
Memory chips power AI and data centers, but prices swing with cycles. This guide weighs whether micron stock bubble r...
Occidental Petroleum leads the 2026 performance among three top U.S. energy explorers, with EOG Resources and ConocoP...
Despite a tepid hiring climate, new college graduates can still land in high-demand fields. Healthcare support, cyber...
Clark Howard weighs in on helping a family member build credit without jeopardizing your own score, after a May 11, 2...
A new era for AI driven video starts with Gemini Omni. This next generation tool promises to simplify crypto explaine...
Four major tech players are pouring hundreds of billions into AI infrastructure in 2026 while trimming payrolls. Mean...